Grey Wolf Therapeutics (Greywolf Therapeutics) is a clinical-stage biotechnology company developing a new therapeutic class of immunotherapies through antigen modulation, aimed at treating people living with cancers and autoimmune disorders.
company autoimmune biotechnology immunotherapy oncology pharmaceuticals immuno-oncology apis-json clinical-stage antigen-modulation erap1
-
Updated
Aug 2, 2026